Screener / SEC EDGAR /CIK 0001674862 /10-K filed Nov 20, 2025, compared with Nov 18, 2024 /Numbers from the XBRL of the 10-Ks
NYSE Industrials · Chemicals & Allied Products

Ashland Inc. ASH

Compare with peers Embed
What it said it expected, against what it reported

5 targets with a reported result

Releases of the last 3 years
Above the range 1 above the last range given
Within the range 1 of 5 range targets
Below the range 3 below the last range given

The numbers ASH said it expected, in its earnings releases, next to what it then reported for the same period.

Target by target

Each target, with the sentence it came from · release and 10-Q or 10-K

The last range givenReported, abovewithin or keptbelow or missed
TargetWhat the company saidReportedResult
EBITDA (company-defined)
Fiscal 2027
Given $405.00M to $435.00M release Nov 3, 2026
– No standard number
The company's words
Issues outlook for full‑year fiscal 2027 sales of $1,905-$1,975 million and Adjusted EBITDA of $405-$435 million release Nov 3, 2026
Revenue
Fiscal 2027
Given $1.91B to $1.98B release Nov 3, 2026
– Not reported yet
The company's words
Issues outlook for full‑year fiscal 2027 sales of $1,905-$1,975 million and Adjusted EBITDA of $405-$435 million release Nov 3, 2026
EBITDA (company-defined)
Fiscal 2026
Given $400.00M to $430.00M release Nov 4, 2025
Lowered $400.00M to $420.00M release Feb 2, 2026
Lowered $385.00M to $400.00M release Apr 28, 2026
Kept $385.00M to $400.00M release Jul 28, 2026
– No standard number
The company's words
Full-year fiscal 2026 guidance … Adjusted EBITDA: $400 million to $430 million release Nov 4, 2025
Ashland reports first quarter fiscal 2026 results and narrows full-year outlook … Narrowing full‑year fiscal 2026 Adjusted EBITDA guidance to $400–$420 million, reflecting approximately $11 million of temporary impacts from the Calvert City startup delay and recent weather-related disruptions, isolated to the second quarter release Feb 2, 2026
Ashland reports second quarter fiscal 2026 results and updates full-year outlook … Updating full‑year fiscal 2026 sales guidance to $1,835-$1,870 million and Adjusted EBITDA guidance to $385-$400 million, primarily reflecting a slower than expected productivity ramp at Hopewell release Apr 28, 2026
Reaffirming full‑year fiscal 2026 sales guidance of $1,835-$1,870 million and Adjusted EBITDA guidance of $385-$400 million release Jul 28, 2026
Revenue
Fiscal 2026
Given $1.83B to $1.91B release Nov 4, 2025
Lowered $1.83B to $1.87B release Apr 28, 2026
Kept $1.83B to $1.87B release Jul 28, 2026
– Not found in XBRL
The company's words
Full-year fiscal 2026 guidance … Sales: $1,835 million to $1,905 million , reflecting organic growth of approximately one to five percent over the prior year release Nov 4, 2025
Updating full‑year fiscal 2026 sales guidance to $1,835-$1,870 million and Adjusted EBITDA guidance to $385-$400 million, primarily reflecting a slower than expected productivity ramp at Hopewell release Apr 28, 2026
Reaffirming full‑year fiscal 2026 sales guidance of $1,835-$1,870 million and Adjusted EBITDA guidance of $385-$400 million release Jul 28, 2026
EBITDA (company-defined)
Fiscal 2025 (ended Sep 30, 2025)
Given $430.00M to $470.00M release Nov 6, 2024
Kept $430.00M to $470.00M release Jan 28, 2025
Lowered $400.00M to $410.00M release Jul 29, 2025
– No standard number
The company's words
For fiscal year 2025, Ashland’s outlook is based on the following assumptions: … For fiscal year 2025, Ashland expects sales to be in the range of $1.90 billion to $2.05 billion, and Adjusted EBITDA to be in the range of $430 million to $470 million. release Nov 6, 2024
Overall, Ashland continues to expect full fiscal year sales in the range of $1.90 billion to $2.05 billion and Adjusted EBITDA in the range of $430 million to $470 million. release Jan 28, 2025
Based on these factors, Ashland now expects full-year fiscal 2025 sales of approximately $1.825 billion to $1.850 billion and Adjusted EBITDA in the range of $400 million to $410 million. release Jul 29, 2025
Revenue
Fiscal 2025 (ended Sep 30, 2025)
Given $1.90B to $2.05B release Nov 6, 2024
Kept $1.90B to $2.05B release Jan 28, 2025
Lowered $1.82B to $1.90B release Apr 30, 2025
Lowered $1.82B to $1.85B release Jul 29, 2025
$1.82B
10-K filed 2025-11-20
Below the range
The company's words
For fiscal year 2025, Ashland expects sales to be in the range of $1.90 billion to $2.05 billion, and Adjusted EBITDA to be in the range of $430 million to $470 million. release Nov 6, 2024
Overall, Ashland continues to expect full fiscal year sales in the range of $1.90 billion to $2.05 billion and Adjusted EBITDA in the range of $430 million to $470 million. release Jan 28, 2025
Based on these factors, Ashland now projects full fiscal year sales in the range of$1.825 billion to $1.9 billionand adjusted EBITDA in the range of$400 million to $420 million. release Apr 30, 2025
Based on these factors, Ashland now expects full-year fiscal 2025 sales of approximately $1.825 billion to $1.850 billion and Adjusted EBITDA in the range of $400 million to $410 million. release Jul 29, 2025
EBITDA (company-defined)
Fiscal 2024 (ended Sep 30, 2024)
Given $460.00M to $500.00M release Jan 30, 2024
Raised $470.00M to $500.00M release Apr 30, 2024
Lowered $465.00M to $475.00M release Aug 6, 2024
– No standard number
The company's words
For the full fiscal year, Ashland expects sales in the range of $2.15 billion to $2.25 billion and adjusted EBITDA in the range of $460 million to $500 million. release Jan 30, 2024
For the full fiscal year, Ashland now expects sales in the range of $2.150 billion to $2.225 billion and adjusted EBITDA in the range of $470 million to $500 million. release Apr 30, 2024
For the full fiscal year, Ashland now expects sales of approximately $2.1 billion and adjusted EBITDA in the range of $465 million to $475 million. release Aug 6, 2024
Revenue
Fiscal 2024 (ended Sep 30, 2024)
Given $2.15B to $2.25B release Jan 30, 2024
Lowered $2.15B to $2.23B release Apr 30, 2024
Lowered $2.10B release Aug 6, 2024
$2.11B
10-K filed 2024-11-18
Above the range
The company's words
For the full fiscal year, Ashland expects sales in the range of $2.15 billion to $2.25 billion and adjusted EBITDA in the range of $460 million to $500 million. release Jan 30, 2024
For the full fiscal year, Ashland now expects sales in the range of $2.150 billion to $2.225 billion and adjusted EBITDA in the range of $470 million to $500 million. release Apr 30, 2024
For the full fiscal year, Ashland now expects sales of approximately $2.1 billion and adjusted EBITDA in the range of $465 million to $475 million. release Aug 6, 2024
EBITDA (company-defined)
Q4 of fiscal 2024
Given $130.00M to $140.00M release Aug 6, 2024
– No standard number
The company's words
Overall, for the fiscal-fourth quarter the company expects sales in the range of $530 million to $540 million and adjusted EBITDA in the range of $130 million to $140 million. release Aug 6, 2024
Revenue
Q4 of fiscal 2024
Given $530.00M to $540.00M release Aug 6, 2024
$522.00M
10-K filed 2024-11-18
Below the range
The company's words
Overall, for the fiscal-fourth quarter the company expects sales in the range of $530 million to $540 million and adjusted EBITDA in the range of $130 million to $140 million. release Aug 6, 2024
EBITDA (company-defined)
Q3 of fiscal 2024
Given $138.00M to $148.00M release Apr 30, 2024
– No standard number
The company's words
Overall, for the fiscal-third quarter the company expects sales in the range of $560 million to $580 million and adjusted EBITDA in the range of $138 million to $148 million. release Apr 30, 2024
Revenue
Q3 of fiscal 2024
Given $560.00M to $580.00M release Apr 30, 2024
$544.00M
10-Q filed 2024-08-07
Below the range
The company's words
Overall, for the fiscal-third quarter the company expects sales in the range of $560 million to $580 million and adjusted EBITDA in the range of $138 million to $148 million. release Apr 30, 2024
EBITDA (company-defined)
Q2 of fiscal 2024
Given $115.00M to $125.00M release Jan 30, 2024
– No standard number
The company's words
Overall, for the fiscal-second quarter the company expects sales in the range of $565 million to $585 million and adjusted EBITDA in the range of $115 million to $125 million. release Jan 30, 2024
Revenue
Q2 of fiscal 2024
Given $565.00M to $585.00M release Jan 30, 2024
$575.00M
10-Q filed 2024-05-01
Within the range
The company's words
Overall, for the fiscal-second quarter the company expects sales in the range of $565 million to $585 million and adjusted EBITDA in the range of $115 million to $125 million. release Jan 30, 2024

Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (12 releases since 2024-01-30), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.

Sources

The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.

Also

Earnings releases: each release in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ASH/export.csv") into a cell.

Next:Archive
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.